The Trump administration announced proposed rules Wednesday to allow states to establish programs to import drugs from Canada and to give drug companies a path to importing less-expensive international versions of the drugs sold.
The Department of Health and Human Services proposals, first promised in July, consist of two drug importation pathways falling under Food and Drug Administration oversight. The first would permit states to draw up plans for importing drugs from Canada detailing which pharmacies or wholesalers would bring FDA-approved drugs to the United States.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.